He said some of the reasons cited for the decline in exports include absence of blockbuster drugs going off-patent; consolidation of buyers in the US into three large groups with significant bargaining power; and some of the Indian companies shifting their manufacturing bases to the EU, US and other ...
Read more: Dip in pharma exports due to shifting of manufacturing bases, market consolidation: Government